Ritlecitinib Impurity 7 CAS CATO-C4X-32987
| CAS No. | CATO-C4X-32987 |
| Molecular Formula | C30H38N10O2 |
| Molecular Weight | 570.69 g/mol |
| Category | Pharmacopoeial Impurity Standards / EP Impurities |
| Availability | In Stock |
Chemical Structure
Description
The molecular framework of Ritlecitinib Impurity 7 (C30H38N10O2) is characterized by a steroid core, an amide group, a hydroxyl group, an ether linkage. In reversed-phase chromatography, its retention is governed primarily by the protonation state of its nitrogen-containing groups, which provides a practical basis for HPLC-UV/DAD or LC-MS method development. The presence of an aromatic ring or conjugated system gives the compound characteristic absorption bands in the UV-Vis region, making it well suited to UV or diode-array detection (DAD).
As a process- or degradation-related impurity, Ritlecitinib Impurity 7 (CAS CATO-C4X-32987, C30H38N10O2) is essential for impurity profiling, related-substances testing, and forced-degradation studies in pharmaceutical development.
Recommended for quantitative analysis by HPLC, GC, LC-MS/MS, or GC-MS as an external calibration standard; it can also be used for spiked-recovery experiments, LOD/LOQ determination, and LC-MS/MS multiple-reaction-monitoring (MRM) calibration.
CATO manufactures Ritlecitinib Impurity 7 under ISO 17034:2016 accreditation with dual CNAS and ANAB accreditation. Each batch is characterized by orthogonal methods and supplied with a full Certificate of Analysis (COA), ensuring metrological traceability.
Physical & Chemical Properties
| Molecular Formula | C30H38N10O2 |
| Molecular Weight | 570.69 g/mol |
| Appearance | Pale yellow to yellow crystalline powder |
| Purity | ≥95% |
| Storage | Store in a cool place (≤25°C), protect from light, keep sealed and dry |
| Solubility (reference) | Soluble in DMSO, DMF, methanol |
| Stability | May oxidize slowly on prolonged air exposure; Light-sensitive; avoid direct strong light; Hygroscopic; reseal immediately after opening |
| Degree of Unsaturation (DBE) | 17.0 |
| UV Absorption | UV-absorbing |
| Structural Features | Aromatic ring present |
| Nitrogen Atoms | 10 |
Related Ritlecitinib Standards
- Ritlecitinib Impurity 8 (CAS CATO-C4X-32988)
- Ritlecitinib (CAS 1792180-81-4)
- Ritlecitinib impurity 4 (CAS 1792181-97-5)
- Ritlecitinib impurity 5 (CAS 1792180-79-0)
- Ritlecitinib Impurity 6 (CAS 1792181-98-6)
- Ritlecitinib impurity 1 (CAS 1271024-76-0)
- Ritlecitinib impurity 2 (CAS 1799311-98-0)
- Ritlecitinib impurity 3 (CAS 1932293-70-3)
Recommended Standards
- Atracurium EP Impurity C (CAS CATO-C4X-185063)
- tert-Butyl 3-{[1,1'-Biphenyl]-4-yl}-4-(4-phenoxybenzenesulfonyl)piperazine-1-carboxylate (CAS 1253527-69-3)
- (Perbromophenyl)methyl methacrylate (CAS 60631-75-6)
- (2S,3S,4S,5R,6S)-3,4,5-tris(benzyloxy)-6-(p-tolylthio)tetrahydro-2H-pyran-2-carboxylic acid (CAS 1400906-88-8)
- Dotinurad Impurity 186 (CAS CATO-C4X-2494186)
- Atorvastatin impurity 165 (CAS CATO-C4X-1132165)
- Mefatinib Impurity 16 (CAS CATO-C4X-299216)
- (S)-2-Octyloxirane (CAS 81623-66-7)
- 3-(4-Bromo-1h-pyrazol-1-yl)-2-(propylamino)propanoic acid (CAS 1247809-37-5)
- 4-(4-Bromophenyl)piperidine, 97% (CAS 80980-89-8)
- 2-Chloro-3-(3-chloropropyl)-7-methylquinoline (CAS 159383-56-9)
- 1h-Imidazole-5-carbohydrazide (CAS 18329-78-7)
- N-(2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)ethyl)-N-(tert-butoxycarbonyl)glycine (CAS 143192-34-1)
- His-Cyclic-Semaglutide (CAS CATO-C4X-2226182)
Why CATO?
- ISO 17034 accredited reference material producer (CNAS + ANAB dual accreditation)
- 130,000+ catalog items in stock, COA supplied with every batch
- Worldwide shipping with full export documentation (HS code guidance available)
- Technical support: +86 18665070610 / Nicole.chen@cato-chem.com